@
hippyjoe1955 Your data appears to be incorrect... Or at least you're incorrectly interpreting it.
from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
which was retrieved on 16th July 2021 and updated on July 13th at the time of retrieval.
Thrombosis with thrombocytopenia syndrome (TTS) after Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccination is rare. As of July 12, 2021, more than 12.8 million doses of the J&J/Janssen COVID-19 Vaccine have been given in the United States. CDC and FDA identified 38 confirmed reports of people who got the J&J/Janssen COVID-19 Vaccine and later developed TTS. Women younger than 50 years old especially should be aware of the rare but increased risk of this adverse event.
So only 38 confirmed deaths through clotting.
Reports of death after COVID-19 vaccination are rare. More than 334 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through July 12, 2021. During this time, VAERS received 6,079 reports of death (0.0018%) among people who received a COVID-19 vaccine. FDA requires healthcare providers to report any death after COVID-19 vaccination to VAERS, even if it’s unclear whether the vaccine was the cause.
So the 7,000 you quote are all reports of death who have recently received a vaccine. However there is no direct proven link with causality.
Finally in the UK the estimate is over 10,000 deaths prevented through vaccination, and that estimation was made in April long before our infection rates hit their current levels.
Public Health England (PHE) analysis indicates that the COVID-19 vaccination programme prevented 10,400 deaths in those aged 60 and older in England up to the end of March, an additional 4,300 since the previous update.
From 8 December 2020 to the end of March 2021, over 15 million vaccine doses were given to adults aged 60 and over. The analysis compared the observed number of deaths with the number of deaths that would have been expected if the vaccine hadn’t been given during this time period. To allow for the time taken to develop an immune response to vaccination, the analysis assumed it would take 31 days before the effect of vaccination on deaths is observed.
Using this method, PHE estimates that around 10,400 deaths were prevented to the end of March – 9,100 in those aged 80 and over, 1,200 in those aged 70 to 79 and 100 in those aged 60 to 69.
Expected deaths with coronavirus (COVID-19) were estimated using real-world data on how effective the vaccines are at preventing death and vaccine uptake.
This analysis takes into account the direct effects of vaccines, there is now increasing evidence that vaccines help to reduce transmission, therefore it is likely that an even higher number of deaths will have been prevented by the vaccination programme.
Source - https://www.gov.uk/government/news/covid-19-vaccines-have-prevented-10-400-deaths-in-older-adults published 8th April 2021 retrieved 16th July 2021